自 196 7年Ｐｏｒｓｔｍａｎｎ等首次报道经心导管封堵动脉导管未闭 (ＰＤＡ)以来[1] ,利用介入性方法治疗其他心内缺损 ,如房间隔缺损 (ＡＳＤ)、卵圆孔未闭、体肺侧支等已有近 30年的历史[2 11] 。目前 ,上述各项技术已相对成熟 ,并广泛应用于临床。然而 ,先天性心脏病中发 Since 196 Porstmann et al. First reported the percutaneous transcatheter closure of the patent ductus arteriosus (PDA) [1], an interventional approach was used to treat other intracardiac defects such as atrial septal defect (ASD), patent foramen ovale, Pulmonary collateral has nearly 30 years of history [2 11]. At present, the above technologies are relatively mature and widely used in clinical practice. However, congenital heart disease occurs